Search for: "Actavis, Inc."
Results 1 - 20 of 51
Sorted by Relevance | Sort by Date
29 Dec, 2008 12:47 pm
... for Public Integrity (the Center, for short). The most surprising part of that article, to me, was this contention by the drug company: Actavis maintains that none of the
improperly manufactured Digitek pills ever reached the public, telling the Center that it recalled ... a press release to announce a Consent Decree that the drug company had agreed to
enter into with the FDA: Actavis Inc. today announced that it has reached agreement on a Consent Decree of Permanent Injunction with the Food and ...
14 Nov, 2008 3:23 pm
... Pills (Posted by Tom Lamb at DrugInjuryWatch.com) A November 13, 2008 Bloomberg article, "Actavis Sued by U.S. Regulators to Shut Heart Drug Manufacturer", got our ... FDA,
the public, our employees and our customers," said John LaRocca, Actavis Inc.'s Chief Legal Officer. "Last month, we asked FDA ... Obama to 'clean house'", Representative
Bart Stupak said the Complaint for an injunction stopping Actavis from manufacturing generic drugs at its Little Falls, New Jersey facility is "posturing" by FDA ...
23 Jun, 2008 11:55 am
... of the international generic pharmaceutical company Actavis Group, is initiating a Class 1 nationwide recall of Digitek (digoxin tablets, USP, all strengths) for oral use.
The products are distributed by Mylan Pharmaceuticals, Inc. under a "Bertek" ... at a more serious issue, that of accountability and liability for those defective Digitek pills.
Who is the responsible party, Actavis or Mylan or both? According to a June 12, 2008 article, "Families Suing Mylan For Medication Mistake", published ...
23 May, 2008 7:20 am
The Court of Appeal has now reached its decision in Actavis UK v Merck Co, Inc. By way of background, Merck is the proprietor of a number of patents related to a drug
called Finasteride. That drug is the active ... form of Finasteride for the treatment of male pattern balding. Finasteride blocks the activity of an enzyme which causes the balding.
Actavis sought to revoke the patent under which Propecia was marketed. At the priority date of the Propecia patent (October 1993), Merck was already in ...
21 Jan 6:02 am
Barrister Jane Lambert writes in her 500th post at her NIPC blog: This was a claim by Actavis for the revocation of a Novartis's European patent for a preparation which released
fluvastatin (a cholesterol inhibiting ... The claim and counterclaim came on before Mr Justice Warren and is reported at Actavis UK Ltd v Novartis AG [2009] EWHC 41 (Ch) (16
January ... ). Mr Justice Warren reviewed that case and others such as Windsurfing International Inc. v Tabur Marine (Great Britain) Ltd [1985] RPC 59 and ...
28 May, 2008 9:27 am
... . A defect in the fold-over of the patch was reportedly causing leakage of gel and forced the initial recall. A month later, as a precaution, Actavis recalled all of its
remaining lots to be sold in the U.S. The manufacturer contracted to make the patches by Actavis is Corium International, Inc. Fentanyl transdermal patches are for
chronic-pain treatment in opiate-tolerant patients. They work by slowly releasing Fentanyl in gel form ...
5 Jun, 2008 8:23 am
Actavis UK Ltd v Merck and Co Inc Court of Appeal "Unlike human rights law, where the Court of Appeal had to refer to the House of Lords a case involving a decision of the
European Court of Human Rights which conflicted with an earlier Court of Appeal decision, since patent law was much more specialist than human rights law, the Court of Appeal was free
to depart from its own previous decision where it was satisfied that the European Patent Office Boards of Appeal had formed a settled ...
4 Nov, 2008 6:18 am
... , is a prescription drug that was recalled from the market in April of 2008 by manufacturers Actavis Totowa, LLC; Actavis, Inc.; Actavis US; Mylan,
Inc.; Mylan Pharmaceuticals, Inc.; Mylan Laboratories, Inc.; Mylan Bertek Pharmaceuticals; and UDL Laboratories, Inc. Currently, more than 50 lawsuits have
been filed against these manufacturers alleging personal injuries and wrongful deaths associated with a manufacturing defect in the ...
27 Mar, 2008 8:41 am
... Jim as a partner in my firm. Please read the article and listen to the podcast (linked below): Jim Orr on Actavis generic Fentanyl patch recallLegal Broadcast Network March
22, 2008 Frequent guest and contributor, Attorney Jim Orr of the ... Speaking of Justice host Scott Drake to discuss the recent recall of a generic based copy of the Duragesic patch.
The product defect recall by Actavis Inc, the U.S based arm of the international drug manufacturing company Actavis Group hf, is important to note ...
Listen Now:
3 Aug 7:29 am
... filed actions had no common defendant. Furthermore, five of the cases were in advanced stages of litigation, and to join them would have delayed resolution of those cases. All
responding defendants (Actavis, Inc.; Actavis-Elizabeth, L.L.C.; Barr Pharmaceuticals, Inc.; Baxter Healthcare Corp.; Duramed Pharmaceuticals, Inc.;
Pliva, Inc.; Pliva USA, Inc.; Schwarz Pharma, Inc.; Teva Pharmaceuticals USA, Inc.; and Wyeth) opposed centralization, as did one Plaintiff ...
11 May 5:00 am
... Copley v. Wyeth, No. 09-722, 2009 WL 1089663 (E.D. Pa. Apr. 22, 2009), Suzanne Copley filed a complaint against Wyeth, Inc.; Wyeth Pharmaceuticals, Inc.; Schwarz
Pharma, Inc.; Actavis, Inc.; and Actavis Elizabeth LLC in Pennsylvania state court for injuries she ... on February 17, and Schwarz removed the case to
federal court on February 19. Wyeth Pharmaceuticals, Inc., is a citizen of Pennsylvania, the state in which the lawsuit was filed. If Wyeth had been properly "joined and ...
7 Jun, 2008 3:34 am
... be prescribed." Johnson & Johnson recalled approximately 32 million patches because of possible leak defects. The recall includes Duragesic® and Sandoz brands. Actavis
Inc., the United States manufacturing and marketing division of the international generic pharmaceutical company Actavis Group HF announced that 14 lots of fentanyl
transdermal system CII patches sold in the United States are being voluntarily recalled. Once ...
29 Oct 3:13 am
... Pine order. See generally Lore v. Lone Pine, No. L-336006-85, 1986 WL 637507 (N.J. Super. Ct. Nov. 18, 1986). Dozens of product liability cases alleging that defendants
Actavis Totowa LLC, Actavis Inc. and Actavis Elizabeth LLC marketed Digitek tablets containing double the appropriate dosage were transferred to an MDL
assigned to Chief Judge Goodwin of the Southern District of West Virginia last summer. In Re: Digitek Products Liability Litigation, MDL ...
7 Oct 9:59 pm
... signature pages. The agreement ends the litigation over a generic version of Eloxatin®, a colon cancer drug manufactured and marketed by Sanofi (see "Biotech/Pharma Docket," July
14, 2009). Sanofi originally filed suit against Sun, Sandoz, Actavis Inc., and Par Pharmaceutical Inc., among other generic manufacturers, in June 2007, accusing
them of infringing Sanofi's patent covering Eloxatin®, U.S. Patent...
25 Jul, 2008 11:56 pm
... oral tablets of all strengths. Digitek is distributed by Mylan Pharmaceuticals, Inc. under a "Bertek" label and by UDL Laboratories, Inc. under a "UDL" label.The
voluntary recall of the Digitek tablets manufactured at the New Jersey Actavis facility occurred because tablets may have been commercially released in the U.S. market with
double the thickness of the normal sized tablets. The flawed Digitek tablets ...
7 Jun, 2007 1:55 am
... patentable second medical use is occasionally a subject of dispute, a neat example being Actavis UK Ltd v Merck & Co Inc [2007] EWHC 1311 (Ch), an English Patents
Court decision from Mr Justice Warren yesterday, available here on BAILII. ... in nothing more novel than a dosage scheme for treatment of the same disorder as previously treated.
According to Actavis, '382 disclosed the therapeutic application - the treatment of androgenic alopecia. Warren J agreed with Actavis ...
12 May, 2008 8:59 am
... a link to this document, which they describe as the "recall notice": Urgent: Drug Recall -- Digitek® (digoxin tablets, USP) Recall initiated by the manufacturer: Actavis
Totowa LLC (formerly known as Amide Pharmaceuticals, Inc.) Product Distributed by: Mylan ... to March 2006, more than two years before the April 2008 announcements by
Actavis and the FDA: Mylan Pharmaceuticals Inc. is continuing a voluntary recall of the Actavis Totowa recall of Digitek® (digoxin tablets, USP). This product is
being ...
4 Jul, 2007 10:50 pm
... (Olanzapine) here. On Tuesday Mr Justice Warren gave judgment in Actavis UK Ltd v Merck & Co Inc, a decision picked up so far only on the LexisNexis Butterworth
subscription-only service. Actavis successfully applied to revoke Merck's patent for the treatment of androgenic alopecia in humans (see ... of lack of inventive step. The judge
thus had to decide whether a percentage reduction of Actavis's total costs was appropriate, or whether an issue-based approach was more appropriate to ...
30 Apr, 2008 2:18 pm
... 28 MedWatch Safety Alert came several days after a press release about this Digitek manufacturing problem was issued by Actavis Totowa LLC (formerly known as Amide
Pharmaceutical Inc). Therein, the manufacturer said it is recalling all strengths of Digitek because it may have accidentally ... . P.S. According to a brief newspaper article
dated April 25, 2008, "Digitek heart drug recall": [Actavis Totowa LLC spokesman] John LaRocca said 11 people have reported getting sick after taking the drug, but ...
22 May, 2008 3:22 am
... Justices Ward, Jacob and Rimer) awaiting him: it's Actavis UK Ltd v Merck & Co Inc [2008] EWCA Civ 444 against the decision ... state of the art". Merck held a
patent for anti-baldness drug finasteride, which Actavis wanted to revoke. At the patent's priority date, back in 1993, Merck sold ... novel than a dosage scheme for treatment of
the same disorder as previously treated. According to Actavis, '382 disclosed the therapeutic application - the treatment of androgenic alopecia. Warren J agreed ...
Search on: Blawgs.FM | BlawgSearch Google Co-op | Blawg.com | Bloglines | Feedster | Google Blog Search | Technorati | Google | MSN | Yahoo!